O'Brien Greene & Co’s Calumet Specialty Products CLMT Stock Holding History

O'Brien Greene & Co’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-29,200	Closed	-$469K	–	138
2024 Q2	$469K	Sell	29,200 -32,500	-53%	-$513K	0.15%	88
2024 Q1	$917K	Buy	61,700 +11,700	+23%	+$186K	0.3%	58
2023 Q4	$894K	Buy	50,000 +2,000	+4%	+$32.4K	0.31%	57
2023 Q3	$917K	Buy	+48,000	New	+$831K	0.34%	52
2021 Q1	–	Sell	-33,001	Closed	-$103K	–	129
2020 Q4	$103K	Sell	33,001 -7,000	-17%	-$24.4K	0.04%	117
2020 Q3	$102K	Sell	40,001 -18,839	-32%	-$48.4K	0.05%	103
2020 Q2	$134K	Buy	+58,840	New	+$126K	0.07%	100

Other funds holding CLMT

WDOM

Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

DMKJ

David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCM

Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

AFA

Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return

O'Brien Greene & Co's CLMT Position: Q3 2024 in Review

O'Brien Greene & Co sold out of Calumet Specialty Products (CLMT) in Q3 2024, closing a stake of 29,200 shares — an estimated $469K sold.

O'Brien Greene & Co first reported a position in CLMT in Q2 2020 and held it in 7 quarters. The position peaked at $917K in Q1 2024. 91 funds tracked by Wall St. Rank hold CLMT as of Q3 2024.

O'Brien Greene & Co reported no remaining Calumet Specialty Products position as of Q3 2024 after selling out during the quarter.
O'Brien Greene & Co sold 29,200 Calumet Specialty Products shares in Q3 2024, an estimated $469K.
O'Brien Greene & Co first reported a position in Calumet Specialty Products in Q2 2020 and held it in 7 quarters.
O'Brien Greene & Co's Calumet Specialty Products position peaked at $917K in Q1 2024.
91 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2024.

Based on O'Brien Greene & Co's 13F filing for Q3 2024, filed 15 Nov 2024.